抗生素耐药淋病奈瑟菌的新趋势：美国全国及夏威夷视角
Emerging Trends in Antibiotic Resistant Neisseria gonorrhoeae: A National and Hawai'i Perspective.
作者信息
Katz Alan R, Komeya Alan Y, Dewater Jo M, Tomas Juval E, Chinna Lance, Wasserman Glenn M
机构信息
Office of Public Health Studies, Myron B. Thompson School of Social Work, University of Hawai'i at Manoa, Honolulu, HI (ARK).
Communicable Disease and Public Health Nursing Division, Hawai'i Department of Health, Honolulu, HI (ARK, AYK, JMD, JET, GMW).
出版信息
Hawaii J Health Soc Welf. 2020 Mar 1;79(3):68-70.
Gonorrhea is the second most common nationally notifiable infectious disease in the United States. Rates have been increasing nationally as have antibiotic-resistant isolates. Both the Centers for Disease Control and Prevention and the World Health Organization have recognized antibiotic-resistant Neisseria gonorrhoeae as a major public health threat and have warned of the emerging threat of "untreatable" gonorrhea. Hawai'i has been on the front lines nationally for gonococcal antimicrobial susceptibility surveillance due to its long-standing, statewide gonococcal isolate surveillance program coupled with antibiotic susceptibility testing of all isolates, and Hawai'i's geographic location between Asia where drug-resistant strains originate, and the continental United States. This article highlights emerging trends in and current status of antibiotic resistant Neisseria gonorrhoeae from a national and Hawai'i perspective.
淋病是美国全国通报的第二大常见传染病。全国范围内淋病发病率一直在上升，耐抗生素菌株也在增加。美国疾病控制与预防中心以及世界卫生组织都已认识到耐抗生素淋病奈瑟菌是对公共卫生的重大威胁，并就“无法治愈”淋病这一新兴威胁发出了警告。由于夏威夷长期实施全州范围的淋病奈瑟菌分离株监测计划，并对所有分离株进行抗生素敏感性测试，且其地理位置处于耐药菌株起源的亚洲与美国大陆之间，因此在全国淋病抗菌药物敏感性监测方面处于前沿。本文从全国和夏威夷的角度突出了耐抗生素淋病奈瑟菌的新趋势和现状。
Zotero 插件